Duopharma Biotech Berhad reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was MYR 169.24 million compared to MYR 177.07 million a year ago. Net income was MYR 8.97 million compared to MYR 16.35 million a year ago. Basic earnings per share from continuing operations was MYR 0.0093 compared to MYR 0.0172 a year ago. Diluted earnings per share from continuing operations was MYR 0.0093 compared to MYR 0.0172 a year ago.
For the nine months, sales was MYR 537.23 million compared to MYR 544.76 million a year ago. Net income was MYR 44.14 million compared to MYR 52.95 million a year ago. Basic earnings per share from continuing operations was MYR 0.0461 compared to MYR 0.0559 a year ago. Diluted earnings per share from continuing operations was MYR 0.0461 compared to MYR 0.0559 a year ago.